TrialThe New England journal of medicine2020
First-Line Lorlatinib or Crizotinib in Advanced
Alice T Shaw et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
647 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialThe New England journal of medicine2020
Alice T Shaw et al.PubMed ↗Publisher ↗
No numbers read from the abstract.